AMRX - Amneal Pharmaceuticals, Inc.

QQQ $ 623.12 $ 0.00 (0 %)

DIA $ 470.55 $ 0.00 (0 %)

SPY $ 676.27 $ 0.00 (0 %)

TLT $ 89.75 $ 0.00 (0 %)

GLD $ 367.21 $ 0.00 (0 %)

Previous Close

$ 11.195

Open

$ 10.76

Bid

$ 10.58 x 1

Ask

$ 11.35 x 200

Day's Range

-- - --

52 Week Range

$ 6.69 - $ 11.20

Volume

2,055,584

Average Volume

Market Cap

3.52B

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

$ 1,041.81

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	02-28-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-03-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-08-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-07-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-06-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	03-02-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-05-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-01-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	03-09-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Piper Sandler Reiterates Overweight on Amn...
10/31/2025 15:38:03

Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight and raises the price ...

Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

Amneal Pharmaceuticals Raises FY2025 Adj E...
10/30/2025 10:02:04

Amneal Pharmaceuticals (NASDAQ:AMRX) raises FY2025 Adj EPS guidance from $0.70-$0.75 to $0.75-$0.80 vs $0.77 analyst estimate. ...

Amneal Pharmaceuticals Q3 Adj. EPS $0.17 B...
10/30/2025 10:00:56

Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate o...

Amneal Pharmaceuticals Granted FDA Tentati...
10/29/2025 20:07:59

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administra...

Amneal Launches Brekiya DHE Autoinjector F...
10/27/2025 12:04:08

teva-viatris-on-investor-watch-as-white-house-spares-generic-drugs-from-tariffs

Teva, Viatris On Investor Watch As White H...
10/09/2025 13:31:09

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply...

Amneal Pharma Submits BLA To FDA For Propo...
09/26/2025 12:05:38

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ("Amneal" or the "Company") today announced the submission of a Bio...

FDA Approves Amneal Pharmaceuticals's Abbr...
09/23/2025 12:04:53

JP Morgan Maintains Overweight on Amneal P...
09/16/2025 11:38:50

JP Morgan analyst Chris Schott maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight and raises the price target ...

Amneal Announces FDA Approval Of Sodium Ox...
09/11/2025 12:07:39

Amneal Pharmaceuticals Announce sFDA Appro...
09/04/2025 20:01:41

Amneal Pharmaceuticals Raises FY2025 Adj E...
08/05/2025 10:02:35

Raising Full Year 2025 Financial GuidanceThe Company is raising its previously provided full year 2025 guidance.Updated Guidanc...

Amneal Pharmaceuticals Q2 2025 Adj. EPS $0...
08/05/2025 10:01:06

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

A Peek at Amneal Pharmaceuticals's Future ...
08/04/2025 16:03:58

Amneal Pharma's Subsidiary Pursues $1.8B T...
07/21/2025 11:45:16

Amneal Pharmaceuticals, Inc. ("Amneal") (NASDAQ:AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the &#...

Amneal Pharma Preliminary Q2 Net Revenue $...
07/21/2025 11:43:25

– Results Reflect Continued Financial Strength and Deleveraging –BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Ph...

NY State Attorney General Letetia James Po...
07/10/2025 17:49:09

https://x.com/NewYorkStateAG/status/1943364781936607687

Amneal Pharmaceuticals Highlights Confirma...
06/25/2025 12:08:09